nu ien s
Re iew
Lep in and Nu i ion in Ges a ional Diabe es
An onio Pé ez-Pé ez 1,*, Te esa Vila iño-Ga cía1, Pila Guadix 2, JoséL. Dueñas 2
and Víc o Sánchez-Ma gale 1,*
1Depa men o Medical Biochemis y and Molecula Biology, and Immnology, School o Medicine,
Vi gen Maca ena Uni e si y Hospi al, 41009 Se ille, Spain; [email p o ec ed]
2Obs e ics and Gynecology Se ice, Vi gen Maca ena Uni e si y Hospi al, 41009 Se ille, Spain;
[email p o ec ed] (P.G.); [email p o ec ed] (J.L.D.)
*Co espondence: [email p o ec ed] (A.P.-P.); [email p o ec ed] (V.S.-M.);
Tel: +34-955008111 (A.P.-P. & V.S.-M.)
Recei ed: 18 May 2020; Accep ed: 30 June 2020; Published: 2 July 2020


Abs ac :
Lep in is highly exp essed in he placen a, mainly by ophoblas ic cells, whe e i has an
impo an au oc ine ophic e ec . Mo eo e , inc eased lep in le els a e ound in he mos equen
pa hology o p egnancy: ges a ional diabe es, whe e lep in may media e he inc eased size o he
placen a and he e us, which becomes mac osomic. In ac , lep in media es he inc eased p o ein
syn hesis, as obse ed in ophoblas s om ges a ional diabe ic subjec s. In addi ion, lep in seems
o acili a e nu ien s anspo o he e us in ges a ional diabe es by inc easing he exp ession o
he glyce ol anspo e aquapo in-9. The high plasma lep in le els ound in ges a ional diabe es
may be po en ia ed by lep in esis ance a a cen al le el, and obesi y-associa ed in lamma ion plays
a ole in his lep in esis ance. The e o e, he impo ance o an i-in lamma o y nu ien s o modi y
he pa hology o p egnancy is clea . In ac , nu i ional in e en ion is he i s -line app oach o
he ea men o ges a ional diabe es melli us. Howe e , mo e nu i ional in e en ion s udies wi h
nu aceu icals, such as polyphenols o polyunsa u a ed a y acids, o nu i ional supplemen a ion
wi h mic onu ien s o p obio ics in p egnan women, a e needed in o de o achie e a high le el
o e idence. In his con ex , he Medi e anean die has been ecen ly ound o educe he isk o
ges a ional diabe es in a mul icen e andomized ial. This e iew will ocus on he impac o
ma e nal obesi y on placen al in lamma ion and nu ien s anspo , conside ing he mechanisms
by which lep in may in luence ma e nal and e al heal h in his se ing, as well as i s ole in
p egnancy pa hologies.
Keywo ds:
nu i ion; polyphenolic compounds; bioac i e compounds; lep in esis ance; obesi y;
in lamma ion; ges a ional diabe es melli us; Medi e anean die
1. In oduc ion
Ges a ional diabe es (GDM) is a hype glycemic s a e ha is ecognized o he i s ime du ing
p egnancy [
1
], and i s pa hophysiology is no ully cla i ied ye . GDM is one o he mos common
complica ions in p egnancy, a ec ing 3–8% o all p egnancies [
2
]. This p e alence has inc eased in
ecen decades (
≥
20% o p egnancies in some pa s o he wo ld), bo h in de eloped and de eloping
coun ies, due o inc eased a e age age o p egnan women and inc eased obesi y [
3
], one o he g ea es
public heal h challenges o he 21s cen u y. Al hough he GDM pheno ype is highly he e ogeneous [
4
],
hal o i s p e alence can be explained by o e weigh and obesi y [
5
]. Indeed, obese women ha e an
inc eased isk o GDM compa ed o women o no mal weigh [
4
]. Mo eo e , in women wi h GDM,
p e-p egnancy obesi y, excessi e ges a ional weigh gain and poo glycemic con ol a e also linked wi h
o he s p egnancy complica ions, such as ges a ional hype ension and p eeclampsia [
6
]. I has e en
been epo ed ha excessi e ges a ional weigh gain was he a iable wi h he g ea es e ec on he
Nu ien s 2020,12, 1970; doi:10.3390/nu12071970 www.mdpi.com/jou nal/nu ien s
Nu ien s 2020,12, 1970 2 o 18
p obabili y o a newbo n wi h mac osomia (a condi ions associa ed wi h an inc eased isk o pe ina al
mo ali y and neona al mo bidi y). GDM also inc eases, in u n, he isk, in bo h mo he and o sp ing,
o de eloping ype 2 diabe es, me abolic synd ome and obesi y [
7
,
8
]. The e o e, obesi y du ing
p egnancy is an impo an isk ac o o ad e se heal h ou comes bo h in he mo he and o sp ing,
and imposes subs an ial economic bu dens. The e o e, p e en ion o obesi y would be di ec ly ela ed
o a lowe isk o GDM. Impai ed glucose homeos asis in GDM is also ela ed o highe p oduc ion o
eac i e oxygen species (ROS), consequen ly deple ing he an i-oxida i e s a us. This is why, o es ain
he sp ead o epidemic excess weigh , women mus ecei e a comp ehensi e in e en ion be o e,
du ing, and a e p egnancy. Li es yle changes, including nu i ion ini ia ed du ing ea ly p egnancy,
ha e been unsuccess ul o e all in p e en ing GDM in a - isk obese women [
9
]. Now, he e is a
consensus ega ding he need o e ec i e in e en ions a ge ing obesi y and li es yle ha educe he
me abolic bu den ea lie in li e, well be o e mo he hood, and i unde lines ha such in e en ions
may bene i bo h he mo he and he u u e o sp ing. Al hough ene gy es ic ion leading o weigh
loss is a success ul die a y in e en ion o imp o ing obesi y-associa ed me abolic diso de s, o he
die a y in e en ions, such as hose leading o a educ ion in adipose issue in lamma ion ega dless o
weigh loss, ha e no been explo ed in de ail. In his sense, lep in, p oduced by adipocy es, is a key
egula o o appe i e and is p esen in ele a ed concen a ions in obesi y [
10
]. The e o e, new esea ch
in o nu i ional mechanisms ha es o e lep in me abolism and signals o ene gy homeos asis may
inspi e new ea men op ions o obesi y- ela ed diso de s such as GDM. In his e iew, we wan ed
o add ess he cu en insigh s and eme ging concep s on po en ially aluable nu ien s and ood
componen s o modula e lep in me abolism. Mo eo e , obesi y is associa ed wi h a ch onic low-g ade
in lamma ion in he adipose issue [
11
], and se e al die a y ood componen s, such as phenols, pep ides,
and i amins, a e able o dec ease he g ade o in lamma ion and imp o e lep in sensi i i y by up-
o down- egula ion o lep in- ela ed genes. O he s ood componen s, such as sa u a ed a y acids
should be a oided, since hey may wo sen ch onic in lamma ion, subsequen ly inc easing he isk
o pa hological complica ions. Finally, gi en he c ucial ole ha he placen a plays in media ing
p egnancy ou comes, i is impo an o conside he impac o mic onu ien supplemen a ion on he
mechanisms associa ed wi h placen al unc ion, as well as ma e nal and e al homeos asis.
2. Lep in
The ho mone lep in, disco e ed in 1994 [12], c i ically egula es body weigh and me abolism a
cen al le el in he b ain [
13
], and dis up ion o lep in/lep in ecep o (LEPR) signaling esul s in mo bid
obesi y and se e e me abolic disease [
14
,
15
]. In indi iduals o no mal weigh , he b ain esponds
o inc eased plasma lep in le els by educing ood in ake and inc easing ene gy expendi u e [
16
,
17
].
Lep in and lep in ecep o s a e highly exp essed in he p eop ic a ea (POA), in he a cua e nucleus
(ARC) o he hypo halamus as well as in o he egions, such as he la e al hypo halamus, en omedial
hypo halamus and do somedial hypo halamus (DMH) [
18
]. The e, i egula es ene gy homoeos asis
and he neu oendoc ine unc ion, among o he unc ions [
19
]. In hese egions, lep in signaling is
media ed by he JAK2/S a 3 pa hway, in which se e al nega i e egula o s o JAK2, including SOCS3
and PTP1B, ha e been epo ed o p omo e obesi y [
20
,
21
], suppo ing he no ion ha JAK2 inhibi o y
molecules inc ease isk o lep in esis ance and obesi y. The e o e, hype lep inemia and hypo halamic
in lamma ion in die -induced obesi y may ac i a e a common nega i e egula o o lep in signaling,
SOCS3 o PTP1B, and con ibu e o cen al lep in esis ance. In ac , up- egula ion o SOCS3 in
p oopiomelanoco in (POMC) neu ons leads o impai men o STAT3 signaling, wi h consequen ial
lep in esis ance and obesi y, as well as glucose in ole ance [
22
]. I has also been epo ed ha mice
wi h whole body o neu on-speci ic dele ion o PTP1B a e hype sensi i e o lep in, and a e esis an o
die -induced obesi y [
23
]. Impo an ly, obesi y is associa ed wi h impai ed adipose sympa he ic ne e
ansmissions [
24
,
25
], bu he unde lying mechanism is poo ly unde s ood. In his con ex , he lep in
esis ance a a cen al le el may p e en nega i e eedback on he an i-in lamma o y ac ion o he
sympa he ic ne ous sys em (SNS) [
15
,
26
]. Tha is why lep in is now conside ed one o he adipokines
Nu ien s 2020,12, 1970 3 o 18
esponsible o he in lamma o y s a e ound in obesi y ha could p edispose o GDM. Su p isingly,
Sh2b1 (an SH2 and PH domain-con aining adap o p o ein) [
27
,
28
] has eme ged as an endogenous
sensi ize o lep in ac ion on he sympa he ic ne ous sys em (SNS) and ene gy expendi u e, pe haps
by enhancing JAK2 ac i a ion [
29
]. In his way, he LepR Sh2b1 neu on media es lep in s imula ion o
he SNS and suppo s he p ese a ion o adipose SNS agains degene a ion [30].
Apa om he JAK-2/S a -3 pa hway, ac i a ion o he MC4R signaling pa hway by
p oopiomelanoco in (POMC)-de i ed melanocy e s imula ing ho mone (MSH) pep ides also
ep esen s a c i ical con e gence poin in he con ol o body weigh . The lep in–melanoco in pa hway
(MC4R pa hway) in eg a es pa allel inpu s om he o exigenic pep ides gh elin, neu opep ide
Y (NPY) and agou i- ela ed pep ide (AgRP), and ac i a ion o he MC4R pa hway dominan ly
coun e ac s hese o exigens. Limi ed e icacy o li es yle in e en ion in indi iduals wi h mu a ions in
gene-encoding componen s o his pa hway demons a es i s impo ance in he con ol o body weigh
homeos asis [31,32].
The e o e, lep in can ac as me abolic swi ch connec ing he nu i ional s a us o he body o
high ene gy-consuming p ocesses. This is especially impo an in p egnancy, whe e lep in no only
modula es sa ie y and ene gy homoeos asis in he mo he [
13
,
33
], bu i is also p oduced by he
placen a, which esponds o he en i onmen a emp ing o main ain e al iabili y. This placen al
p oduc ion o lep in is one o he majo sou ces o highe le els o ma e nal ci cula ing lep in o he
han ma e nal gain o a mass [
34
]. Thus, he e ec s o placen al lep in on he mo he may con ibu e
o endoc ine-media ed al e a ions in ene gy balance, such as he mobiliza ion o ma e nal a , which
could u he agg a a e he insulin esis ance associa ed wi h p egnancy and he onse o GDM [
35
,
36
].
In ac , obese p egnan women ha e signi ican ly ele a ed plasma lep in concen a ions compa ed wi h
nonobese p egnan women h oughou p egnancy [
1
]. Mo eo e , ma e nal obesi y is also associa ed
wi h changes in he placen al unc ion and s uc u e, which likely impac e al g ow h and de elopmen .
Fo example, obesi y has been associa ed wi h se e al changes ela ed mainly wi h placen al size,
hype ascula iza ion, highe b anching capilla ies o he illi (cho angiosis) [
37
,
38
] and inc eased
glycogen deposi s, among o he s. Inc eased mac ophage in il a ion is also e iden in he placen a
o obese women, sugges ing an exagge a ion o he in lamma o y s a e which occu s in no mal
p egnancy [
39
]. Howe e , i is unclea which his ological changes a e due o he pa hophysiology and
which a e compensa o y adap a ions o his disease. Rega dless, al e a ions in placen al nu ien and
ho mone anspo e capaci y ha e been demons a ed in human and animal models o obesi y, and a e
hypo hesized as a mechanism leading o an accele a ed e al g ow h ajec o y and mac osomia [
1
].
In his sense, we ha e demons a ed ha he inc eased exp ession o aquapo in-9 (AQP9) (o o he s
aquaglyce opo ins) obse ed in placen as om obese women wi h GDM could be media ed by
hype lep inemia, sugges ing an inc ease in he anspo o glyce ol o he e us and hus con ibu ing
o he inc eased ene gy in ake equi emen s in he mac osomic e us in GDM [
40
]. Lep in has also been
iden i ied as a c i ical ophic ac o ha in luences he de elopmen o he hypo halamic p ojec ions [
40
].
Al e a ions in he pa e n o lep in sec e ion (p ema u e peak, excess, o de iciency) du ing neona al
li e could ha e signi ican ad e se e ec s on hypo halamic de elopmen and me abolic pheno ype [
41
]
(Figu e 1).
Finally, one o he pe iphe al unc ions o lep in is a egula o y ole in he in e play be ween
ene gy me abolism and he immune sys em, which is, in pa , esponsible o he in lamma o y s a e
associa ed o obesi y [
42
]. Se e al in lamma o y media o s p oduced by in lamma o y cells also
egula e lep in exp ession and p omo e he de elopmen o ch onic in lamma ion [
43
]. In his ega d,
lep in e ec s include he in lamma ion and he modula ion o inna e and adap i e immuni y [
44
,
45
].
The e o e, p oin lamma o y lep in ac ions migh also ha e signi ican implica ions in he pa hogenesis
o GDM [29,46].
Taken all oge he , since hypo halamic in lamma ion esul s in cen al lep in esis ance and hepa ic
insulin esis ance [
47
], blocking he pe iphe al and cen al in lamma ion induced by a high a die
could ha e he po en ial o ea obesi y and GDM. The e o e, no el he apies inco po a ing e ec i e
Nu ien s 2020,12, 1970 4 o 18
na u al agen s (mac o and mic onu ien s), pa icula ly agen s wi h he dual p ope ies o p e en ing
in lamma ion and con olling body weigh by imp o ing lep in sensi i i y, migh be an al e na i e
in e en ion a ge ing obesi y and GDM.
Nu ien s 2020, 12, x FOR PEER REVIEW 4 o 19
p e en ing in lamma ion and con olling body weigh by imp o ing lep in sensi i i y, migh be an
al e na i e in e en ion a ge ing obesi y and GDM.
Figu e 1. E ec s o bioac i e ood compounds on he lep in esis ance associa ed wi h obesi y and
ges a ional diabe es.
Lep in le els a e inc eased in ges a ional diabe es wi h obesi y (1). The high plasma lep in le els
may be po en ia ed by lep in esis ance a cen al le el, in which SOCS3 and PTPB a e induced by
lep in and in ol ing in a nega i e eed-back loop. The esul ing e ec is a dec ease in he lep in-
induced ac i a ion o he JAK2/STAT-3 signaling, leading o a educ ion in he cen al e ec s o lep in
(2). Lep in also impac s he placen a i sel in an au oc ine/pa ac ine ashion. The in eg a ion o
nume ous signaling by in acellula egula o y pa hways such as MAPK, PI3K and JAK-STAT has
been demons a ed o inc ease he size o he placen a and o a ec placen al nu ien anspo and
e al g ow h (mac osomia) (3). Bioac i e ood compounds such as polyphenols migh educe
ci cula ing lep in le els, pa ly dec easing lep in exp ession in he placen a om women wi h GDM.
The esul ing e ec is a dec ease in he lep in esis ance a a cen al le el and op imal placen al
nu ien s anspo .
3. Nu ien s and Bioac i e Food Componen s Use ul o Coun e ac ing Hype lep inemia and
Lep in Resis ance in GDM
Since he landma k Hype glycemia and Ad e se P egnancy Ou comes (HAPO) s udy in 2010,
an in e na ional consensus on diagnos ic c i e ia has no been eached nea ly a decade la e [47].
Howe e , he e is now a consensus ega ding he need o e ec i e in e en ions a ge ing obesi y.
In his ega d, since i s -line medical (pha maceu ical) he apy has ecen ly been called in o ques ion
[48] and he socioemo ional componen o nu i ion he apy o GDM has a dominan in luence on
adhe ence [49], o he die a y s a egies should be u he in es iga ed in de ail. Fo example, since
die plays an impo an ole in in lamma ion, and bo h obesi y and GDM a e conside ed a s a e o
ch onic in lamma ion, a heal hy and ac i e li e s yle, which includes a die ich in ui s, ege ables,
non-suga ed oods, non-ul a-p ocessed oods associa ed wi h a highe p e en ion o in lamma o y
diseases should be inco po a ed in o he die [50]. Howe e , a high consump ion o ed, p ocessed
Figu e 1.
E ec s o bioac i e ood compounds on he lep in esis ance associa ed wi h obesi y and
ges a ional diabe es.
Lep in le els a e inc eased in ges a ional diabe es wi h obesi y (1). The high plasma lep in
le els may be po en ia ed by lep in esis ance a cen al le el, in which SOCS3 and PTPB a e induced
by lep in and in ol ing in a nega i e eed-back loop. The esul ing e ec is a dec ease in he
lep in-induced ac i a ion o he JAK2/STAT-3 signaling, leading o a educ ion in he cen al e ec s o
lep in (2). Lep in also impac s he placen a i sel in an au oc ine/pa ac ine ashion. The in eg a ion o
nume ous signaling by in acellula egula o y pa hways such as MAPK, PI3K and JAK-STAT has been
demons a ed o inc ease he size o he placen a and o a ec placen al nu ien anspo and e al
g ow h (mac osomia) (3). Bioac i e ood compounds such as polyphenols migh educe ci cula ing
lep in le els, pa ly dec easing lep in exp ession in he placen a om women wi h GDM. The esul ing
e ec is a dec ease in he lep in esis ance a a cen al le el and op imal placen al nu ien s anspo .
3. Nu ien s and Bioac i e Food Componen s Use ul o Coun e ac ing Hype lep inemia and
Lep in Resis ance in GDM
Since he landma k Hype glycemia and Ad e se P egnancy Ou comes (HAPO) s udy in 2010, an
in e na ional consensus on diagnos ic c i e ia has no been eached nea ly a decade la e [
47
]. Howe e ,
he e is now a consensus ega ding he need o e ec i e in e en ions a ge ing obesi y. In his
ega d, since i s -line medical (pha maceu ical) he apy has ecen ly been called in o ques ion [
48
]
and he socioemo ional componen o nu i ion he apy o GDM has a dominan in luence on
adhe ence [
49
], o he die a y s a egies should be u he in es iga ed in de ail. Fo example, since
die plays an impo an ole in in lamma ion, and bo h obesi y and GDM a e conside ed a s a e o
ch onic in lamma ion, a heal hy and ac i e li e s yle, which includes a die ich in ui s, ege ables,
non-suga ed oods, non-ul a-p ocessed oods associa ed wi h a highe p e en ion o in lamma o y
diseases should be inco po a ed in o he die [
50
]. Howe e , a high consump ion o ed, p ocessed
mea , sa u a ed o ans- a , ul a-p ocessed ood based on e ined ing edien s o alcohol associa ed
wi h p o-in lamma o y p ocesses should be a oided [35,36].
Nu ien s 2020,12, 1970 5 o 18
Since obese women and women wi h GDM show high ci cula ing lep in le els and a e hence
conside ed lep in- esis an [
51
,
52
], we ha e iden i ied nu i ional s a egies o coun e ac lep in
esis ance in bo h obesi y and GDM. In his con ex , se e al mic o- and mac o-nu ien s and bioac i e
ood componen s migh ha e he abili y o inc ease lep in sensi i i y and o e e se lep in esis ance in
obesi y and GDM.
3.1. Polyphenolic Compounds
Polyphenolic compounds such as la onoids ep esen an impo an bioac i e componen in
plan s ( ui s, ege ables, legumes, ea, e c.) wi h some speci ic pa s o hese oods iche in la onoids
han o he s ( o example he peel o ce ain ui s) [
53
]. The accumula ion o la onoids o en occu s in
plan s subjec ed o abio ic s esses. This ac has made hei de e mina ion an a ac i e ield in ood
science and, in ecen yea s, an inc eased numbe o s udies ha e analyzed hei po en ial bene i s in
human heal h.
As men ioned abo e, bo h he impac o nu i ional s a us on he immune sys em, specially T
cells [
54
,
55
] and he ole o lep in as a media o o in lamma ion [
42
], as well as a link be ween ene gy
s o es and he immune esponse, ha e been p oposed [
56
,
57
]. In his sense, he (poly)phenols migh
modula e bo h he lep in e ec and ci cula ing lep in le els using di e en expe imen al app oaches.
Fo example, i has been epo ed ha la onoids ha e an i-in lamma o y p ope ies and hus ha e an
impo an ole in he con ol o se e al immune cells and immune mechanisms ha a e impo an in
he in lamma o y p ocesses. Mo e speci ically, ce ain la onoids (my ice in, que ce in, p ocyanidins)
can inhibi mul iple cen al kinases ha a e in ol ed in mul iple signaling pa hways ela ed o
in lamma ion [
58
], such as phosphoinosi ol kinase, p o ein kinase C (PKC), phospha idylinosi ol kinase
and y osine kinase o cyclin-dependen kinase-4 [
59
]. Besides, la onoids can modula e hese p o ein
kinases ia inhibi ion o ansc ip ion ac o s (e.g., NF-
κ
B and AP-1) [
60
]. In iguingly, bo h insulin
and lep in sha e se e al signaling pa hways, such as mi ogen-ac i a ed p o ein kinase (MAPK) and
he phospha idylinosi ol 3-kinase (PI3K) pa hway, which may also ac i a e se e al p o ein kinases
in ol ed in signal ansduc ion du ing he in lamma ion p ocess, ia NF-
κ
B. In his con ex , ou g oup
ha e demons a ed ha he inc ease in placen al lep in exp ession is media ed by NF
κ
B signaling [
61
].
The e o e, in GDM, associa ed wi h insulin esis ance, hype insulinemia and hype lep inemia [
62
,
63
],
la onoids migh down egula e he syne gis ic in e ac ion be ween insulin and lep in signaling in he
in lamma o y p ocesses. In addi ion, la onoids migh also dec ease lep in exp ession in he placen a
o women wi h GDM.
I has also been epo ed ha high cAMP le els inhibi lep in exp ession by human cho ionic
gonado opin (hCG), and hese inc eased le els o cAMP ha e been associa ed wi h an i-in lamma o y
unc ions [
64
]. In his sense, la onoids ha e also demons a ed he po en ial o block cAMP deg ada ion
and p olong cAMP signaling [
65
]. Finally, la onoids may ha e an impac on cell ac i a ion, signaling
ansduc ion and cy okine p oduc ion in se e al immune cells. Fo ins ance, la onoids ha e been
shown o inhibi ma u a ion o dend i ic cells (DCs) by supp essing he exp ession o CD83 and CD80,
which would ansla e in o an inhibi o y e ec in he sec e ion o p o-in lamma o y cy okines [
66
,
67
].
These e ec s a e con a y o lep in, which p omo es he swi ch owa ds Th1 cell immune esponses by
inc easing in e e on-
γ
(IFN-
γ
) exp ession and acili a es Th17 esponses. All hese indings posi ion
la onoids as modula o s o immune esponse and, e y speci ically, as inhibi o s o ansc ip ion
ac o s, in ol ed in he exp ession o di e en p o-in lamma o y genes such as he lep in gene [60].
On he o he hand, i is well known ha he imbalance be ween he oxida i e and an i-oxida i e
sys ems plays a c ucial ole in he pa hogenesis o se e al human diseases such as obesi y and
diabe es, among o he s [
68
–
70
]. In his con ex , la onoids a e also po en an ioxidan s ha a e able
o sca enge ee adicals and dec ease hei o ma ion. Fo example, g ape juice by-p oduc s a e
a sou ce o phenolic compounds wi h demons a ed an ioxidan ac i i ies [
71
]. In hese, he main
phenolic compounds include la ones (lu eolin) [
71
,
72
], la onols (my ice in, ise in, que ce in and
kaemp e ol de i a i es) [
70
,
73
], an hocyanins (cyanidin-3-glucoside) [
74
], la an-3-ols (ca echin and

Nu ien s 2020,12, 1970 6 o 18
epica echin monome s and p oan hocyanidins) [
75
,
76
], s ilbenes ( es e a ol), and phenolic acids [
74
].
The mos s udied o hese is es e a ol, which has been demons a ed o diminish ci cula ing
lep in le els and o educe in ake [
77
] by inc easing phospho-STAT3 con en in he hypo halamus,
wi h no changes in SOCS3. This sugges ha es e a ol migh imp o e he lep in sensi i i y in
obesi y [78,79]. P oan hocyanidins (PACs), known as condensed annins, a e ound in a wide a ie y
o ui s (e.g., be ies), in addi ion o g apes, and o he sou ces such as lowe s, seeds o some plan s,
nu s o ba ks [
80
,
81
]. Plan and ood-de i ed PACs a e also a ac ing a en ion due o hei abili y
o p e en ch onic diseases [
82
]. Fo example, PACs om g ape seeds and blackbe y–bluebe y
e men ed be e ages ha e shown high an i-in lamma o y and an ioxidan ac i i y
in i o
[
83
] and
ha e shown a b oad he apeu ic heal h e ec agains diabe es melli us and obesi y. In his ega d,
obesi y and ela ed complica ions such as GDM a e linked wi h highe suscep ibili y o oxida i e s ess
and he adminis a ion o g ape seed ex ac s has shown an imp o emen in he oxida i e s a us in
obese people by inhibi ing lipid pe oxida ion and a oiding ROS p oduc ion [
84
]. Mo eo e , PACs can
educe in lamma ion by dec easing he oxida i e s ess o o he indi ec mechanisms [
85
]. In his sense,
PACs om g ape seed ex ac modula e IL-6, TNF-
α
and adiponec in gene exp ession in adipose issue,
hus, educing he die -induced low-g ade in lamma ion [
86
]. PAC- ich ex ac s ha e also p o ed o be
in ol ed in obesi y modula ion (e en a low doses) h ough he supp ession o ood in ake and he
inc ease in ene gy expendi u e [
87
], possibly by media ing lep in le els. Howe e , he mechanism
unde lying his e ec o g ape seed PACs has no been ully elucida ed. Finally, g ape seed ex ac
imp o ed he insulin esis ance index as well as he plasma glucose and insulin le els in die -induced
obese animal models [88], al hough he e a e disc epancies in his ega d.
O he bioac i e ood compounds ha e also been p o en o be able o educe ci cula ing lep in
le els in obesi y. My ice in, a bio la onoid abundan in o he s ui s (e.g., be ies), as well as
ea and ege ables, has been shown o educe hype lep inemia and o a o insulin ac ion ia
PI3-kinase pa hway ac i a ion, and ansloca ion o glucose anspo e sub ype 4 (GLUT4) o he cell
memb ane [
89
]. Accumula ing e idence also sugges s ha p opolis ex ac s ( ich in la onoids and
cinnamic acid de i a i es) ha e he apeu ic e ec s on obesi y by con olling adipogenesis, adipokine
sec e ion, ood in ake, and ene gy expendi u e. Pa icula ly, conside ing he ano ec ic ac i i y o lep in,
p opolis has po en ial o a enua e eeding and subsequen ly p e en obesi y [
90
]. Mo eo e , a ious
epo s in animal and cellula models ha e demons a ed ha p opolis and i s de i ed compounds
imp o e insulin sec e ion and insulin sensi i i y by modula ing oxida i e s ess, he accumula ion o
ad anced glyca ion end p oduc s (AGEs), and adipose issue in lamma ion, all o which con ibu e o
insulin esis ance o de ec s in insulin sec e ion [
91
,
92
]. Fo example, se e al la onoids in p opolis,
such as que ce in, ch ysin, lu eolin, amen o la one, lu eolin 7-O-glucoside and daidzein, ha e been
ound o ha e he apeu ic e ec s in diabe ic animal models by di e en mechanisms [
93
,
94
]. I has
also been epo ed ha p opolis mi iga es me abolic dys unc ion h ough no maliza ion o in es inal
mic o lo a [
95
]. The e o e, p opolis in ake migh ha e bene icial e ec s o me abolic diso de s such as
GDM, a ibu able o la onoids and na u al phenols. Howe e , p opolis migh ha e ad e se e ec s
on pa ien s and, he e o e, moni o ing o biological e ec s should be ca ied ou .
The polyphenols o oli es and oli e lea es also ha e nume ous bene icial e ec s on human heal h,
such as an ioxidan capaci y, hypoglycemic [
96
] and an i-in lamma o y [
97
], as well as a coadju an
ole in he ea men o obesi y [
98
]. In his sense, oleu opein, esponsible o he bi e as e o oli e
lea es and d upes, and i s de i ed o m, he mos abundan phenolic compounds p esen in oli es
and oli e oils, a e well known o hei hypoglycemic p ope y; possibly by he po en ial o a ec ing
glucose-induced insulin elease and/o inc easing pe iphe al glucose up ake [
99
]. This hypoglycemic
e ec is also a ibu ed, a leas in pa , o he an ioxidan ac i i y o oleu opein [
100
]. Mo eo e , i has
been epo ed ha oleu opein down- egula es lep in mRNA le els in epididymal adipose issue and
educes se um lep in le els [
101
]. Tha is why he p ophylac ic use o oleu opein has been p oposed in
he educ ion in complica ions esul ing om oxida i e s ess in obesi y and diabe es [
99
]. O he majo
phenolic componen s p esen —no only in oli e ex ac s bu in ui s (e.g., g apes), such as lu eolin
Nu ien s 2020,12, 1970 7 o 18
and lu eolin-4
0
-O-
β
-D-glucopy anoside—ha e been shown o inhibi he o ma ion o AGEs and, hus,
migh delay he de elopmen o diabe ic complica ions [
96
]. Howe e , hese e ec s ha e been es ed
in animals and i is necessa y o pe o m s udies in humans in o de o con i m he bene i s a ibu ed
o polyphenols om oli es in GDM.
3.2. Polyunsa u a ed Fa y Acids (PUFAs)
The de eloping e us equi es subs an ial amoun s o a y acids o suppo apid cellula g ow h
and ac i i y, and especially, me abolic de i a i es o he essen ial a y acids such as linolenic acid (
Ω
-3)
and linoleic acid (
Ω
-6) and polyunsa u a ed a y acids (PUFAs) a e c ucial [
102
]. The mos biologically
impo an PUFAs a e docosahexaenoic acid (DHA) and eicosapen aenoic acid (EPA) [
102
]. In his
con ex , DHA appea s o be c ucial o he e us and in an o ea ly neu al de elopmen (b ain and
isual sys em) [
103
]. Howe e , mode n die a y ends ha e led o an imbalance in he consump ion
o PUFAs, wi h de iciency in
Ω
-3 and inc easing
Ω
-6 PUFA in ake which a exceeds nu i ional
equi emen s, p omo ing he pa hogenesis o many p e alen human diseases including GDM [104].
The placen a may play a key ole in he egula ion o a y acid a ailabili y ia he elease o
placen al-de i ed lep in, a po en s imula o o lipolysis [
105
]. In ac , ma e nal ci cula ing o al a y
acid concen a ions inc ease du ing p egnancy, enhancing placen al access o a y acids. Howe e ,
as men ioned abo e, GDM is associa ed wi h oxida i e s ess and placen al in lamma ion [
106
], and
impai ed placen al a y acid anspo has been epo ed [107].
Gi en ha PUFAs exhibi bo h an i-oxida i e and an i-in lamma o y ac i i ies, ma e nal die a y
DHA and EPA supplemen a ion has been p oposed as a po en ial he apeu ic in e en ion o
his placen a- ela ed diso de . Fo example, ma e nal die a y supplemen a ion wi h
Ω
-3 PUFAs
du ing p egnancy exe s bene icial e ec s such as educed in lamma ion by ei he dis up ing
p oin lamma o y eicosanoid gene a ion o p omo ing he gene a ion o an i-in lamma o y o ms [
108
].
Mo eo e , i has been also epo ed ha die a y supplemen a ion wi h
Ω
-3 PUFAs modula es he
ac i i y o key ansc ip ion ac o s (pe oxisome p oli e a o -ac i a ed ecep o s (PPARs) and/o
nuclea ac o
κ
B (NF-
κ
B)) and he G-p o ein-coupled ecep o (GPR120) in ol ed in in lamma o y
signaling
[109–111]
. Consequen ly, die a y supplemen a ion wi h
Ω
-3 PUFAs migh educe isk o
p egnancy complica ions [
112
] as well as he adipose issue in lamma ion ia GPR120-media ed
supp ession o mac ophage p oin lamma o y cy okine sec e ion, including lep in [
113
]. Indeed,
DHA and EPA ha e been shown o educe ci cula ing lep in le els ac i a ing he adenosine
5’-monophospha e-ac i a ed p o ein kinase (AMPK) pa hway [
114
]. Ano he bene icial e ec o
he
Ω
-3 PUFAs on GPR120 is he inc ease in he ansloca ion o in acellula esicles con aining
GLUT4, which enhances glucose up ake by adipocy es [
111
]. Oleic acid, a monounsa u a ed a y
acid (MUFA), also educes hype lep inemia ia down- egula ing PPAR
γ
mRNA le els in abdominal
isce al whi e adipose issue in obese mice [
115
]. Th ough modula ion o adipokine sec e ion, hese
a y acids also a o insulin sensi i i y [116].
Finally, excessi e oxida i e s ess in u e o-placen al issues plays a pi o al ole in he de elopmen
o GDM [
106
]. In his con ex ,
Ω
-3 PUFAs could po en ially limi oxida i e damage by educing ROS
gene a ion [117]. Howe e , i would be impo an o asce ain he po en ial isks o excessi e die a y
PUFA in ake gi en he suscep ibili y o PUFAs o lipid pe oxida ion, which may exace ba e cellula
damage caused by an oxida i e insul [118].
All oge he , hese indings highligh he po en ial bene i o die a y supplemen a ion wi h PUFAs
o limi oxida i e damage and in lamma ion associa ed wi h obesi y and GDM, al hough u he
esea ch in humans is equi ed o cla i y whe he hese a y acids can p e en GDM and he po en ial
isks associa ed i hey a e used as supplemen s.
3.3. Te penes
The e is e idences ha ca es ol and/o i s me aboli es (kahweol), na u al di e penes ex ac ed
om co ee beans, can p e en some ch onic diseases such as me abolic disease [
119
–
121
]. In his
Nu ien s 2020,12, 1970 8 o 18
con ex , i has been demons a ed ha ca es ol p omo es insulin sec e ion and also inc eased glucose
up ake in muscle cells, simila ly o ha o an idiabe ic osigli azone. Mo eo e , kahweol can ac i a e
he AMPK pa hway, a cen al modula o o he me abolism o glucose and lipid ha s imula es glucose
up ake and inhibi s he lipid accumula ion. A la ge numbe o s udies ha e also shown ha ca es ol
and kahweol ha e an i-in lamma ion and an ioxidan ac i i y, as well as an inhibi o y e ec on cell
p oli e a ion. Mo e speci ically, ca es ol blocks he AP-1 pa hway o educe PGE2 p oduc ion and
blocks he PI3K/Ak pa hway, p omo ing apop osis in umo cells [
122
]. All hese e ec s could be
bene icial in he placen al o e g ow h obse ed in GDM. Howe e , despi e he ac ha ca eine
has been shown o ac i a e STAT-3 ia decline o ER s ess in he hypo halamus [
123
], i has been
epo ed ha kahweol down- egula ed he STAT3 signaling pa hway by inhibi ing i s cons i u i e
phospho yla ion and ac i a ion [
124
], which may agg a a e he lep in esis ance in obesi y. The e o e,
u he esea ch and clinical ials a e needed o con i m whe he he co ee di e penes migh be used
o p e en o ea GDM in humans.
E idence has been epo ed ega ding he e ec o ea p e en ing obesi y and abno mal glucose
and lipid me abolism [
125
]. In his sense, in addi ion o phenolic componen s, a majo bioac i e
componen o ea ex ac is easaponin, a i e pene wi h signi ican an i-in lamma o y p ope ies.
Mo e speci ically, easaponin inhibi s p oin lamma o y cy okines by supp essing NF
κ
B signaling
ups eam o IKK/I
κ
B
α
[
125
]. The an i-in lamma o y e ec s o easaponin ha e been associa ed wi h
an imp o ed glycemic s a us in animal models. Mo eo e , easaponin dec eases he exp ession o
hypo halamic p oin lamma o y cy okines as well as he in lamma o y signaling in he mediobasal
hypo halamus [
125
]. This may con ibu e o imp o ed lep in sensi i i y and hypo halamic lep in
signaling ia p-STAT3. In ac , easaponin signi ican ly dec eases he le el o SOCS3, a nega i e
egula o o cen al lep in signaling in he hypo halamus o high- a die -induced obese mice.
The e o e, easaponin has impo an e ec s in imp o ing glucose ole ance, cen al lep in sensi i i y,
and hypo halamic lep in signaling [
125
], and i migh be a po en ial candida e as he apeu ic in e en ion
o obesi y and GDM.
3.4. P obio ics
Ea ly epo s o expe imen al and human s udies ega ding he ole o gu mic obio a p omo ing
gu ba ie unc ions and con olling in lamma o y esponses ha e a ac ed scien i ic in e es . The gu
mic obio a is highly sensi i e o he die and may be in ol ed in a accumula ion, a o ing hyd olysis
and abso p ion o indiges ible polysaccha ides and, hus, excessi e s o age o nu ien s [
126
,
127
]. In ac ,
a dis inc i e gu mic obio a composi ion in obesi y has been epo ed in humans [
127
]. Fo example,
a lowe ibe in ake has been epo ed o be associa ed wi h educed gu mic obio a di e si y and
ichness, g ea e abundance o genus associa ed wi h ype 2 diabe es melli us [
128
,
129
], and genus
wi h known p o-in lamma o y capaci y [
34
]. Physiological weigh gain du ing p egnancy [
130
,
131
]
also in luences he gu mic obio a composi ion in pa allel wi h weigh gain, a o ing a highe
numbe o Bi idobac e ium spp and a lowe p opo ion o S aphylococcus spp [
132
]. These shi
in mic obial composi ion a e mo e p onounced in obese p egnancy and women wi h o e weigh
gain du ing p egnancy [
130
–
133
]. The e o e, a easonable s a egy o igh GDM migh be based
on speci ic p obio ics, which migh coun e ac excessi e abso p ion and s o age o nu ien s by
modi ica ion o he gu mic obio a composi ion. P obio ics in GDM migh balance he e ec o abe an
indigenous mic obio a and no malize he inc eased in es inal pe meabili y, as well as he sec e ion
o p oin lamma o y media o s, including lep in. The e o e, as men ioned in a clinical ial [
134
],
speci ic p obio ics o p obio ic oods migh be used as die a y adjunc s o educe he isk o diseases
associa ed wi h abe an gu mic obio a composi ion, inc eased in es inal pe meabili y o al e ed
immunological o me abolic balance such as GDM. In ac , he impac o p obio ics on GDM migh
be mo e p onounced in a high- isk popula ion (e.g., obesi y). Mo eo e , p obio ics supplemen a ion
would no only a ec he ma e nal me abolic s a e, bu would also modula e e al physiology and
migh ha e a long- e m p og amming e ec on child heal h [
135
–
137
]. Howe e , cu en knowledge
Nu ien s 2020,12, 1970 9 o 18
abou gu mic obio a and die esponse in p egnancy complica ed by GDM is limi ed and u u e s udies
ha in eg a e gene ics and clinical a iables should be aken in o accoun .
3.5. O he s Bioac i e Compounds
Lycopene is a lipophilic ca o enoid which is esponsible o he ed colo in a ious ege ables
and ui s, and is commonly ound in oma oes [
138
,
139
]. This ca o enoid is known o i s an ioxidan
and an i-in lamma o y e ec s [
140
], and has been epo ed o imp o e diseases wi h ch onic
in lamma o y backg ounds such as obesi y. As men ioned abo e, hype lep inemia is associa ed
wi h p o-in lamma o y esponses and wi h he ch onic subin lamma o y s a e obse ed in obesi y [
141
].
In his con ex , i has been sugges ed ha lycopene supplemen a ion may a enua e he in lamma o y
esponse in obesi y, a leas in pa , by minimizing hype lep inemia [
142
,
143
]. O he bioac i e
compounds o many c uci e ous ege ables (e.g., wa e c ess and b occoli) a e iso hiocyana es (ITCs),
cha ac e ized by he p esence o hiol- eac i e chemicals ha can modi y c i ical cys eine esidues on
a a ie y o cellula p o eins [
144
–
146
]. As men ioned abo e, accumula ing e idence sugges s ha
PTP1B could be in ol ed in he pa hways leading o lep in esis ance as a majo nega i e egula o
o lep in and insulin signaling. In his sense, ITCs ha e been ound o inac i a e PTP1B [
147
,
148
],
which has a eac i e cys eine esidue a he ca aly ic cen e [
147
]. Pa icula ly, phene hyl iso hiocyana e
(PEITC), a ela i ely non oxic cons i uen , in addi ion o inhibi ing cellula PTP1B ac i i y, has been
demons a ed o enhance phospho yla ion o LEPRb, JAK2, and STAT3 in he hypo halamus, esul ing
in he s imula ion o lep in signaling and signi ican ly educed ood in ake [149].
3.6. Mic onu ien s
Mic onu ien s include nume ous mine als and i amins de i ed om he die ha a e essen ial
o cellula me abolism and op imal issue unc ion. I has been epo ed ha an adequa e supply
o mic onu ien s du ing p egnancy may signi ican ly educe he isk o de eloping diso de s o
p egnancy, including GDM [
150
]. Th oughou he cou se o p egnancy, he e may be inc eased isk
o mic onu ien de iciency in esponse o he equi emen s o he g owing e us [
151
]. The e o e,
al hough a heal hy die would be he ideal way o co e he mic onu ien equi emen s, i is
possible ha he physiological challenge o p egnancy migh equi e addi ional nu i ional suppo
o mic onu ien s [
152
]. The majo i y o supplemen s on he ma ke con ain a wide a ie y o
i amins (B g oup i amins, i amins C, D, E and ola e) and mine als (i on, coppe , zinc, iodine,
selenium [
153
]. Howe e , despi e he bene i s o mic onu ien s in suppo ing ma e nal, placen al,
and e al homeos asis du ing p egnancy [
152
,
154
], insigni ican e idence and a ied esul s ha e been
no ed upon andomized ials o supplemen a ion [
155
]. Such a iabili y may be linked o a ia ions
in speci ic mic onu ien supplemen p epa a ions and popula ion con ex s [
155
]. The e o e, he
possibili y ha mic onu ien s supplemen a ion could p e en complica ions o p egnancy wa an s
u he in es iga ion wi h la ge ials in his ield [151].
4. Medi e anean Die
Despi e he publica ion o nume ous andomized ials on die and li es yle in e en ions in
p egnancy [
156
], as men ioned abo e, no clea die a y ecommenda ions ha e eme ged o imp o e
p egnancy ou comes o women wi h me abolic isk ac o s, pa icula ly GDM. This can be a ibu ed o
he lack o obus e idence on e ec i eness o he die [
157
]. The adi ional die , “Medi e anean die ”,
has long been associa ed wi h p e en i e ac i i y agains ch onic in lamma ion-associa ed diseases,
which a e suppo ed by obse a ional and epidemiological da a. The Medi e anean-s yle die includes
componen s such as a high in ake o nu s, ex a i gin oli e oil, ui , ege ables, non- e ined g ains,
legumes and mic onu ien s, as well as mode a e o high consump ion o ish and low consump ion o
p ocessed mea , suga y d inks, as ood, and ood ich in animal a [
158
]. These key componen s
o his die migh help o con ol he ac i i y o obesi y and GDM as well as o he in lamma o y
pa hologies. In ac , he Medi e anean die has been ecen ly ound o educe he isk o GDM in a
Nu ien s 2020,12, 1970 16 o 18
101.
Hoek- an den Hil, E.F.; an Scho ho s , E.M.; an de S el , I.; Swa s, H.J.M.; an Vlie , M.; Amolo, T.;
Ve oo , J.J.M.; Venema, D.; Hollman, P.C.H.; Rie jens, I.M.C.M.; e al. Di ec compa ison o me abolic heal h
e ec s o he la onoids que ce in, hespe e in, epica echin, apigenin and an hocyanins in high- a -die - ed
mice. Genes Nu . 2015,10. [C ossRe ] [PubMed]
102.
Hagga y, P. Fa y acid supply o he human e us. Annu. Re . Nu .
2010
,30, 237–255. [C ossRe ] [PubMed]
103.
Roge s, L.K.; Valen ine, C.J.; Keim, S.A. DHA supplemen a ion: Cu en implica ions in p egnancy and
childhood. Pha macol. Res. 2013,70, 13–19. [C ossRe ] [PubMed]
104.
Simopoulos, A.P. Impo ance o he omega-6/omega-3 balance in heal h and disease: E olu iona y aspec s o
die . Wo ld Re . Nu . Die . 2011,102, 10–21. [C ossRe ]
105.
Hagga y, P. E ec o placen al unc ion in a y acid equi emen s du ing p egnancy. Eu . J. Clin. Nu .
2004
,
58, 1559–1570. [C ossRe ]
106.
Bu on, G.J.; Jauniaux, E. Oxida i e s ess. Bes P ac . Res. Clin. Obs e . Gynaecol.
2011
,25, 287–299.
[C ossRe ]
107.
Magnusson, A.L.; Wa e man, I.J.; Wenne g en, M.; Jansson, T.; Powell, T.L. T iglyce ide hyd olase ac i i ies
and exp ession o a y acid binding p o eins in he human placen a in p egnancies complica ed by in au e ine
g ow h es ic ion and diabe es. J. Clin. Endoc inol. Me ab. 2004,89, 4607–4614. [C ossRe ]
108.
P esco , S.L.; Ba den, A.E.; Mo i, T.A.; Duns an, J.A. Ma e nal ish oil supplemen a ion in p egnancy modi ies
neona al leuko iene p oduc ion by co d-blood-de i ed neu ophils. Clin. Sci. (Lond.)
2007
,113, 409–416.
[C ossRe ]
109.
Calde , P.C. Fa y acids and in lamma ion: The cu ing edge be ween ood and pha ma. Eu . J. Pha macol.
2011,668 (Suppl. 1), S50–S58. [C ossRe ]
110.
Jawe baum, A.; Capobianco, E. Re iew: E ec s o PPAR ac i a ion in he placen a and he e us: Implica ions
in ma e nal diabe es. Placen a 2011,32 (Suppl. 2), S212–S217. [C ossRe ]
111.
Oh, D.Y.; Talukda , S.; Bae, E.J.; Imamu a, T.; Mo inaga, H.; Fan, W.; Li, P.; Lu, W.J.; Wa kins, S.M.; Ole sky, J.M.
GPR120 is an omega-3 a y acid ecep o media ing po en an i-in lamma o y and insulin-sensi izing e ec s.
Cell 2010,142, 687–698. [C ossRe ] [PubMed]
112.
Oken, E.; Ning, Y.; Ri as-Shiman, S.L.; Rich-Edwa ds, J.W.; Olsen, S.F.; Gillman, M.W. Die du ing p egnancy
and isk o p eeclampsia o ges a ional hype ension. Ann. Epidemiol. 2007,17, 663–668. [C ossRe ]
113.
Jones, M.L.; Ma k, P.J.; Mo i, T.A.; Keelan, J.A.; Waddell, B.J. Ma e nal die a y omega-3 a y acid
supplemen a ion educes placen al oxida i e s ess and inc eases e al and placen al g ow h in he a .
Biol. Rep od. 2013,88. [C ossRe ] [PubMed]
114.
Flachs, P.; Mohamed-Ali, V.; Ho ako a, O.; Rossmeisl, M.; Hosseinzadeh-A a , M.J.; Hensle , M.; Ruzicko a, J.;
Kopecky, J. Polyunsa u a ed a y acids o ma ine o igin induce adiponec in in mice ed a high- a die .
Diabe ologia 2006,49, 394–397. [C ossRe ]
115.
El Akoum, S.; Lamon agne, V.; Clou ie , I.; Tanguay, J.F. Na u e o a y acids in high a die s
di e en ially delinea es obesi y-linked me abolic synd ome componen s in male and emale C57BL/6J
mice. Diabe ol. Me ab. Synd . 2011,3. [C ossRe ] [PubMed]
116.
Kalupahana, N.S.; Claycombe, K.J.; Mous aid-Moussa, N. (n-3) Fa y acids alle ia e adipose issue
in lamma ion and insulin esis ance: Mechanis ic insigh s. Ad . Nu . 2011,2, 304–316. [C ossRe ]
117.
Ha akeyama, Y.; Sca pace, P.J. T ansc ip ional egula ion o uncoupling p o ein-2 gene exp ession in L6
myo ubes. In . J. Obes. Rela . Me ab. Diso d. 2001,25, 1619–1624. [C ossRe ]
118.
Al-Gubo y, K.H. Mi ochond ia: Omega-3 in he ou e o mi ochond ial eac i e oxygen species.
In . J. Biochem. Cell Biol. 2012,44, 1569–1573. [C ossRe ]
119.
Shang, F.; Li, X.; Jiang, X. Co ee consump ion and isk o he me abolic synd ome: A me a-analysis.
Diabe es Me ab. 2016,42, 80–87. [C ossRe ]
120.
Poole, R.; Kennedy, O.J.; Rode ick, P.; Fallow ield, J.A.; Hayes, P.C.; Pa kes, J. Co ee consump ion and heal h:
Umb ella e iew o me a-analyses o mul iple heal h ou comes. BMJ 2017,359, j5024. [C ossRe ]
121.
Ding, M.; Bhupa hi aju, S.N.; Sa ija, A.; an Dam, R.M.; Hu, F.B. Long- e m co ee consump ion and isk
o ca dio ascula disease: A sys ema ic e iew and a dose- esponse me a-analysis o p ospec i e coho
s udies. Ci cula ion 2014,129, 643–659. [C ossRe ]
122.
Shen, T.; Pa k, Y.C.; Kim, S.H.; Lee, J.; Cho, J.Y. Nuclea ac o -
κ
B/signal T ansduce s and ac i a o s o
ansc ip ion-1- media ed in lamma o y esponses in Lipopolysaccha ide-ac i a ed mac ophages a e a majo
inhibi o y a ge o kahweol, a co ee di e pene. Biol. Pha m. Bull. 2010,33, 1159–1164. [C ossRe ]

Nu ien s 2020,12, 1970 17 o 18
123.
Hosoi, T.; Toyoda, K.; Naka su, K.; Ozawa, K. Ca eine a enua ed ER s ess-induced lep in esis ance in
neu ons. Neu osci. Le . 2014,569, 23–26. [C ossRe ]
124.
Kim, H.G.; Hwang, Y.P.; Jeong, H.G. Kahweol blocks STAT3 phospho yla ion and induces apop osis in
human lung adenoca cinoma A549 cells. Toxicol. Le . 2009,187, 28–34. [C ossRe ]
125.
Yu, Y.; Wu, Y.; Szabo, A.; Wu, Z.; Wang, H.; Li, D.; Huang, X.F. Teasaponin educes in lamma ion and cen al
lep in esis ance in die -induced obese male mice. Endoc inology 2013,154, 3130–3140. [C ossRe ]
126.
Zhao, L. The gu mic obio a and obesi y: F om co ela ion o causali y. Na . Re . Mic obiol.
2013
,11, 639–647.
[C ossRe ]
127.
Ley, R.E.; Tu nbaugh, P.J.; Klein, S.; Go don, J.I. Mic obial ecology: Human gu mic obes associa ed wi h
obesi y. Na u e 2006,444, 1022–1023. [C ossRe ]
128.
Ba e , H.L.; Gomez-A ango, L.F.; Wilkinson, S.A.; McIn y e, H.D.; Callaway, L.K.; Mo ison, M.; Dekke
Ni e , M. A ege a ian die is a majo de e minan o gu mic obio a composi ion in ea ly p egnancy.
Nu ien s 2018,10. [C ossRe ]
129.
Gomez-A ango, L.F.; Ba e , H.L.; Wilkinson, S.A.; Callaway, L.K.; McIn y e, H.D.; Mo ison, M.; Dekke
Ni e , M. Low die a y ibe in ake inc eases Collinsella abundance in he gu mic obio a o o e weigh and
obese p egnan women. Gu Mic obes 2018,9, 189–201. [C ossRe ]
130.
Collado, M.C.; Isolau i, E.; Lai inen, K.; Salminen, S. E ec o mo he ’s weigh on in an ’s mic obio a
acquisi ion, composi ion, and ac i i y du ing ea ly in ancy: A p ospec i e ollow-up s udy ini ia ed in ea ly
p egnancy. Am. J. Clin. Nu . 2010,92, 1023–1030. [C ossRe ]
131.
San ac uz, A.; Collado, M.C.; Ga c
í
a-Vald
é
s, L.; Segu a, M.T.; Ma
í
n-Lagos, J.A.; Anjos, T.; Ma
í
-Rome o, M.;
Lopez, R.M.; Flo ido, J.; Campoy, C.; e al. Gu mic obio a composi ion is associa ed wi h body weigh ,
weigh gain and biochemical pa ame e s in p egnan women. B . J. Nu .
2010
,104, 83–92. [C ossRe ]
[PubMed]
132.
Ko en, O.; Good ich, J.K.; Cullende , T.C.; Spo , A.; Lai inen, K.; Kling Bäckhed, H.; Gonzalez, A.; We ne , J.J.;
Angenen , L.T.; Knigh , R.; e al. Hos emodeling o he gu mic obiome and me abolic changes du ing
p egnancy. Cell 2012,150, 470–480. [C ossRe ] [PubMed]
133.
Collado, M.C.; Isolau i, E.; Lai inen, K.; Salminen, S. Dis inc composi ion o gu mic obio a du ing p egnancy
in o e weigh and no mal-weigh women. Am. J. Clin. Nu . 2008,88, 894–899. [C ossRe ]
134.
Luo o, R.; Lai inen, K.; Ne mes, M.; Isolau i, E. Impac o ma e nal p obio ic-supplemen ed die a y
counselling on p egnancy ou come and p ena al and pos na al g ow h: A double-blind, placebo-con olled
s udy. B . J. Nu . 2010,103, 1792–1799. [C ossRe ]
135.
Rau a a, S.; Collado, M.C.; Salminen, S.; Isolau i, E. P obio ics modula e hos -mic obe in e ac ion in he
placen a and e al gu : A andomized, double-blind, placebo-con olled ial. Neona ology
2012
,102, 178–184.
[C ossRe ]
136.
Rau a a, S.; Kainonen, E.; Salminen, S.; Isolau i, E. Ma e nal p obio ic supplemen a ion du ing p egnancy
and b eas - eeding educes he isk o eczema in he in an . J. Alle gy Clin. Immunol.
2012
,130, 1355–1360.
[C ossRe ]
137.
Isolau i, E.; Rau a a, S.; Salminen, S. P obio ics in he de elopmen and ea men o alle gic disease.
Gas oen e ol. Clin. No h. Am. 2012,41, 747–762. [C ossRe ]
138.
Khachik, F.; Ca alho, L.; Be ns ein, P.S.; Mui , G.J.; Zhao, D.Y.; Ka z, N.B. Chemis y, dis ibu ion, and
me abolism o oma o ca o enoids and hei impac on human heal h. Exp. Biol. Med.
2002
,227, 845–851.
[C ossRe ]
139.
Mangels, A.R.; Holden, J.M.; Beeche , G.R.; Fo man, M.R.; Lanza, E. Ca o enoid con en o ui s and
ege ables: An e alua ion o analy ic da a. J. Am. Die . Assoc. 1993,93, 284–296. [C ossRe ]
140.
Ma co o chino, J.; Romie , B.; Gou an on, E.; Riolle , C.; Gleize, B.; Maleze -Desmoulins, C.; Land ie , J.F.
Lycopene a enua es LPS-induced TNF-
α
sec e ion in mac ophages and in lamma o y ma ke s in adipocy es
exposed o mac ophage-condi ioned media. Mol. Nu . Food Res. 2012,56, 725–732. [C ossRe ]
141.
Fan uzzi, G. Adipose issue, adipokines, and in lamma ion. J. Alle gy Clin. Immunol.
2005
,115, 911–919.
[C ossRe ]
142.
Lu izo o, R.D.A.M.; Nascimen o, A.F.; Imaizumi, E.; Pie ine, D.T.; Conde, S.J.; Co ea, C.R.; Yeum, K.J.;
Fe ei a, A.L.A. Lycopene supplemen a ion modula es plasma concen a ions and epididymal adipose issue
mRNA o lep in, esis in and IL-6 in die -induced obese a s. B . J. Nu . 2013,110, 1803–1809. [C ossRe ]
Nu ien s 2020,12, 1970 18 o 18
143.
Sa a anan, S.; Pa i, L. Role o hymol on hype glycemia and hype lipidemia in high a die -induced ype 2
diabe ic C57BL/6J mice. Eu . J. Pha macol. 2015,761, 279–287. [C ossRe ]
144.
Shiba a, T.; Kimu a, Y.; Mukai, A.; Mo i, H.; I o, S.; Asaka, Y.; Oe, S.; Tanaka, H.; Takahashi, T.; Uchida, K.
T ans hioca bamoyla ion o p o eins by hiola ed iso hiocyana es. J. Biol. Chem.
2011
,286, 42150–42161.
[C ossRe ] [PubMed]
145.
Kuma i, V.; Dyba, M.A.; Holland, R.J.; Liang, Y.H.; Singh, S.V.; Ji, X. I e e sible inhibi ion o glu a hione
S- ans e ase by phene hyl iso hiocyana e (PEITC), a die a y cance chemop e en i e phy ochemical.
PLoS ONE 2016,11. [C ossRe ]
146.
C oss, J.V.; Foss, F.W.; Rady, J.M.; Macdonald, T.L.; Temple on, D.J. The iso hiocyana e class o bioac i e
nu ien s co alen ly inhibi he MEKK1 p o ein kinase. BMC Cance 2007,7. [C ossRe ]
147.
Chia ugi, P.; Ci i, P. Redox egula ion o p o ein y osine phospha ases du ing ecep o y osine kinase
signal ansduc ion. T ends Biochem. Sci. 2003,28, 509–514. [C ossRe ]
148.
Lewis, S.M.; Li, Y.; Ca alano, M.J.; Laciak, A.R.; Singh, H.; Seine , D.R.; Reilly, T.J.; Tanne , J.J.; Ga es, K.S.
Inac i a ion o p o ein y osine phospha ases by die a y iso hiocyana es. Bioo g. Med. Chem. Le .
2015
,25,
4549–4552. [C ossRe ] [PubMed]
149.
Yagi, M.; Naka suji, Y.; Maeda, A.; O a, H.; Kamikubo, R.; Miyoshi, N.; Nakamu a, Y.; Akagawa, M. Phene hyl
iso hiocyana e ac i a es lep in signaling and dec eases ood in ake. PLoS ONE 2018,13. [C ossRe ]
150.
Scholl, T.O.; Hedige , M.L.; Bendich, A.; Schall, J.I.; Smi h, W.K.; K uege , P.M. Use o mul i i amin/mine al
p ena al supplemen s: In luence on he ou come o p egnancy. Am. J. Epidemiol.
1997
,146, 134–141.
[C ossRe ]
151.
Black, R.E.; Allen, L.H.; Bhu a, Z.A.; Caul ield, L.E.; de Onis, M.; Ezza i, M.; Ma he s, C.; Ri e a, J. Ma e nal
and child unde nu i ion: Global and egional exposu es and heal h consequences. Lance
2008
,371, 243–260.
[C ossRe ]
152.
Ramak ishnan, U.; G an , F.; Goldenbe g, T.; Zong one, A.; Ma o ell, R. E ec o women’s nu i ion be o e and
du ing ea ly p egnancy on ma e nal and in an ou comes: A sys ema ic e iew.
Paedia . Pe ina . Epidemiol.
2012,26, 285–301. [C ossRe ] [PubMed]
153.
Pe kins, A.V.; Vande lelie, J.J. Mul iple mic onu ien supplemen a ion and bi h ou comes: The po en ial
impo ance o selenium. Placen a 2016,48, S61–S65. [C ossRe ] [PubMed]
154.
S eege s-Theunissen, R.P.M.; Twig , J.; Pes inge , V.; Sinclai , K.D. The pe iconcep ional pe iod, ep oduc ion
and long- e m heal h o o sp ing: The impo ance o one-ca bon me abolism. Hum. Rep od. Upda e
2013
,
19, 640–655. [C ossRe ]
155.
Kawai, K.; Spiegelman, D.; Shanka , A.H.; Fawzi, W.W. Ma e nal mul iple mic onu ien supplemen a ion and
p egnancy ou comes in de eloping coun ies: Me a-analysis and me a- eg ession.
Bull. Wo ld Heal h O gan.
2011,89, 402B–411B. [C ossRe ]
156.
The In e na ional Weigh Managemen in P egnancy (i-WIP) Collabo a i e G oup. E ec o die and physical
ac i i y based in e en ions in p egnancy on ges a ional weigh gain and p egnancy ou comes: Me a-analysis
o indi idual pa icipan da a om andomised ials. BMJ 2017,358, j3119. [C ossRe ]
157.
Rogozi´nska, E.; Ma lin, N.; Jackson, L.; Rayanagouda , G.; Rui ok, A.E.; Dodds, J.; Molyneaux, E.;
an Poppel, M.N.; Pos on, L.; Vin e , C.A.; e al. E ec s o an ena al die and physical ac i i y on ma e nal
and e al ou comes: Indi idual pa ien da a me a-analysis and heal h economic e alua ion. Heal h Technol.
Assess. 2017,21, 1–158. [C ossRe ]
158.
Es uch, R.; Ros, E.; Salas-Sal ad
ó
, J.; Co as, M.I.; Co ella, D.; A
ó
s, F.; G
ó
mez-G acia, E.; Ruiz-Gu i
é
ez, V.;
Fiol, M.; Lape a, J.; e al. P ima y p e en ion o ca dio ascula disease wi h a Medi e anean die .
N. Engl. J. Med. 2013,368, 1279–1290. [C ossRe ]
159.
Al Wa a , B.H.; Dodds, J.; Placzek, A.; Be es o d, L.; Spy eli, E.; Moo e, A.; Gonzalez Ca e as, F.J.; Aus in, F.;
Mu ugesu, N.; Roseboom, T.J.; e al. Medi e anean-s yle die in p egnan women wi h me abolic isk ac o s
(ESTEEM): A p agma ic mul icen e andomised ial. PLoS Med. 2019,16, e1002857. [C ossRe ]
©
2020 by he au ho s. Licensee MDPI, Basel, Swi ze land. This a icle is an open access
a icle dis ibu ed unde he e ms and condi ions o he C ea i e Commons A ibu ion
(CC BY) license (h p://c ea i ecommons.o g/licenses/by/4.0/).